Arthur Manoli, MD
Adult Reconstructive Orthopaedic Surgery · Wilton, CTNPI 1700271137
Payments from drug & device makers
What this record shows
This record is dominated by royalties or licence payments: $16,375 of the $24,794 with a category attached, or 66.0%. DJO, LLC accounts for 66.0% of it on its own, with 11 other manufacturers making up the rest. Reporting peaked in 2020 at $16,416 and has fallen 92.5% since, to $1,226 in 2025.
Across 51 payments — averaging $486.17 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- DJO, LLC$16K
- Ortho Development Corporation$5K
- Stryker$1K
- Maxx Orthopedics, Inc.$1K
- UOC USA Inc$492
- Zimmer Biomet$161
- plus $624 from 6 others
What the payments were for
- Royalty or licence$16,37566%
- Travel & lodging$4,73319%
- Food & beverage$3,68715%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| DJO, LLC | 4 | $16,375 |
| Ortho Development Corporation | 18 | $4,605 |
| Stryker | 2 | $1,342 |
| Maxx Orthopedics, Inc. | 5 | $1,195 |
| UOC USA Inc | 5 | $492 |
| Zimmer Biomet | 4 | $161 |
| Medical Device Business Services, Inc. | 5 | $149 |
| Paragon 28, Inc. | 1 | $148 |
| Orthalign Inc | 3 | $143 |
| Kinamed, Inc. | 1 | $65 |
| Kerecis Limited | 1 | $62 |
| Johnson & Johnson | 2 | $57 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- BKS TriMax$3,357
- Entrada Hip Stem$1,470
- SALVATION$1,289
- Trivicta$226
- APEX 3D$148
- Legend$133
- U2 and USTAR II$123
- U2, Conformity, U-Motion II, U-Star$115
- Balanced Knee Revision System$113
- U2 PF+$102
How this compares
Too few adult reconstructive orthopaedic surgery providers in Connecticutto place this figure against a meaningful peer group, so we don't.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Meloxicam | 93 | $265 |
| Celecoxib | 12 | $144 |
Paid to pharmacies, not to this prescriber.
Other adult reconstructive orthopaedic surgery in Wilton
- Jenna BernsteinTrumbull$273K
- Paul MurrayHartford$64K
- Christopher LynchBranford$48K
- Thomas HickernellStamford$45K
- Elie MansourNew Haven$24K
- Ryan CharetteWallingford$16K
- Derek ShiaHamden$7K
- Donald AllenHartford$7K
- Adam GreenNorth Franklin$6K
- Aidin Eslam PourWest Haven$5K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.